7 min. Read

Digital health formulary wars heat up. $40M price tag for a digital drug.

Issue 007. Digital health formulary wars heat up. $40M price tag for a digital drug.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a likely-not-to-be-repeated 89 percent open rate. Here's what's happening this week:

  • Your editor is preparing to take his 3-year-old and 5-year-old camping for the first time this weekend. Hit reply to talk me out of it (or to send more marshmallows).
  • Dexcom CEO Kevin Sayer told Jim Cramer in the next 12 months the company will launch the G6 version of its CGM that sends data direct-to-Apple Watch (bypassing the iPhone).
  • Benjamin D'hont of Alcimed has a helpful overview of the current state of digital therapeutics here.
  • Elsewhere, I've heard some curmudgeons throwing cold water on digital health companies that call themselves "digital therapeutics" if they use either CBT or real live

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Better Therapeutics shuts down. Mahana-Cara Care
5 min. Read
HCPCS and CPT decisions. Akili results. Click trials
7 min. Read
De Novo: Samsung Galaxy Watch gets OTC sleep apnea detection
7 min. Read
Facebook’s RCT for AI bot Zenny. More trials
7 min. Read
FDA de novo for Google smartphone thermometer.
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
8 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
6 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
8 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
5 min. Read
  • First
  • Previous
  • 1 of 20
  • Next
  • Last